As the healthcare and biopharma ecosystem expands and diversifies, the public-private partnership model offers an important sphere of collaboration between biopharma companies, medical institutions, patient advocacy foundations, and governmental entities. Biopharma companies—many ASAP... Continue Reading
Contributed Content
Thought leadership from our community members.
Alliance Excellence Award
ASAP Publications
ASAP Short Takes
ASAP Webinar
BioPharma Conference
Community Partnership
Contributed Content
European Alliance Summit
Global Alliance Summit
Job Board
Member Resources
Program Executive Summary
Program Executive Summary :
ASAP Roundtables
Program Executive Summary :
Collaborative Connections
Program Executive Summary :
Virtual Programs
Accelerating Medicines and Jump-Starting Treatments: Public-Private Partnerships Enlist Takeda and O
Accelerating Medicines and Jump-Starting Treatments: Public-Private Partnerships Enlist Takeda and O
Date posted01/31/2020
Coopetition Pulse Survey Request from ASAP EPPP Vantage Partners
In today’s rapidly evolving market ecosystems, interactions between companies are neither simple nor static. Companies engage in both competitive and collaborative interactions with one another; companies that were once considered fierce competitors are now also each other’s most... Continue Reading
Date posted12/20/2019
Collaboration: Easier Said Than Done
The following blog was originally posted by ASAP corporate member and Education Provider Partner, The Rhythm of Business. Collaboration is a business buzzword that everyone thinks they know what it means and how to do it, but few truly do; yet it has never been more important than it is today. In... Continue Reading
Postedby Jan Twombly
Date posted12/12/2019